3
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Somatostatin Attenuates the Hyperdynamic Circulatory State in the Gastric Mucosa of Rats with Portal Hypertension

, , &
Pages 921-926 | Received 28 Sep 1994, Accepted 16 Jan 1995, Published online: 08 Jul 2009

References

  • McCormack 'IT, Sims J, Eyre-Brook I, Kennedy H, Goepel J, Johnson A G, et al. Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy?. Gut 1985; 26: 1226–32
  • Tarnawski A, Sarfeh I J, Stachura J, Hajduczek A, Bui H X, Dabros W, et al. Microbascular abnormalities of the portal hypertensive gastric mucosa. Hepatology 1988; 8: 1488–94
  • Panes J, Bordas J, Pique J, Bosch J, Garcia-Pagan J C, Feu F, et al. Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology 1992; 103: 1875–82
  • Pique J M, Leung F W, Kitahora T, Sarfeh I J, Tarnawski A, Guth PH. Gastric mucosal blood flow and acid secretion in portal hypertensive rats. Gastroenterology 1988; 95: 727–33
  • Sarfeh I J, Tarnawski A. Gastric mucosal vasculopathy in portal hypertension. Gastroenterology 1987; 93: 1129–31
  • Ma J J, Cho C H, og le CW. Portal hypertension: its effects on gastric function and ethanol-induced gastric mucosal damage in rats. Dig Dis Sci 1993; 38: 2203–8
  • Sarfeh I J, Tarnawski R, Maeda R, Raymont K, Mason G R, Hey KJ. The gastric mucosa in portal hypertension: effects of topical bile acid. Scand J Gastroenterol 1984; 19: 189–94, Suppl 92
  • Perez-Ayuso R M, Pique J M, Bosch J, Panes J, Gonzalez A, Perez R, et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 1991; 337: 1431–4
  • Leung F W, Jensen D M, Guth PH. Endoscopic demonstration that vasopressin but not propranolol produces gastric mucosal ischemia in dogs with portal hypertension. Gastroint Endosc 1988; 34: 310–3
  • Hung FW, Morishita T, Livingstone E H, Reedy T, Guth PH. Reflectance spectrophotometry for the assessment of gastro-duodenal mucosal perfusion. Am J Physiol 1987; 33: 284–8
  • Sato N, Kamada T, Schichiri M, Kawano S, Abe H, Hagihara B. Measurement of hemoperfusion and oxygen sufficiency in gastric mucosa in vivo. Gastroenterology 1979; 76: 814–9
  • Sacchetti C, Capello M, Rebecchi P, Roncucci L, Zanghieri G, Tripodi A, et al. Frequency of upper gastrointestinal lesions in patients with liver cirrhosis. Dig Dis Sci 1988; 33: 1218–22
  • Triger DR. The natural history and treatment of portal hypertensive gastropathy. J Gastroenterol Hepatol 1989; 4: 8–14, Suppl 1
  • Bosch J, Kravetz D, Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology 1981; 80: 518–25
  • Eriksson L S, Law D H, Sato Y, Wahren J. Influences of somatostatin on splanchnic haemodynamics in patients with liver cirrhosis. Clin Physiol 1984; 4: 5–11
  • Merkel G, Gatta A, Zuin R, Finucci G F, Nosadini R, Ruol A. Effect of somatostatin on splanchnic hernodynamics in patients with liver cirrhosis and portal hypertension. Digestion 1985; 32: 92–8
  • Kravetz D, Bosch J, Arderiu M T, Pizcueta M P, Casamitjana R, Rivera F, et al. Effect of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats. Am J Physiol 1988; 254: G322–8
  • Sieber C C, Mosca P G, Groszmann RJ. Effect of somatostatin in mesenteric vascular resistance in normal and portal hypertensive rats. Am J Physiol 1992; 262: G274–7
  • Hsia G C, Lin H C, Lee F Y, Tsai Y T, Lee S D, Meng H C, et al. Changes of hepatic and systemic hemodynamics following somatostatin administration in patients with hepatitis B-related cirrhosis. J Gastroenterol Hepatol 1993; 8: 15–20
  • Panes J, Pique J M, Bordas J M, Casadevall M, Teres J, Bosch J, et al. Effect of bolus injection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal-hypertensive gastropathy. Hepatology 1994; 20: 336–41
  • Tarnasky P R, Kovacs T OG, Bung FW, Hirabayashi K, Jensen DM. Octreotide decreases canine gastric mucosal blood flow: a controlled assessment by endoscopic reflectance spectrophotometry. Gastrointest Endosc 1994; 40: 56–61
  • Pizcueta M P, Garcia-Pagan J C, Fernandez M, Casamitjana R, Bosch J, Rodes J. Glucagon hinders the effect of somatostatin on portal hypertension: a study in rats with portal vein ligation. Gastroenterology 1991; 101: 1710–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.